Trials / Conditions / Bronchitis, Chronic

Bronchitis, Chronic

27 registered clinical trials studyying Bronchitis, Chronic.

Status	Trial	Sponsor	Phase
Completed	Safety and Feasibility Study of Rejuvenair™ for Treating Chronic Bronchitis Patients NCT02483637	CSA Medical, Inc.	N/A
Completed	Mucolytic Effectiveness of Tacholiquine ® in Chronic Bronchitis NCT02515799	bene-Arzneimittel GmbH	Phase 4
Terminated	Post-hospitalisation Nutritional Support and Gait Speed in COPD NCT02261350	Royal Brompton & Harefield NHS Foundation Trust	Phase 3
Completed	Physical Activity Augmentation Using Pedometers During Pulmonary Rehabilitation in Chronic Obstructive Pulmona NCT01719822	Royal Brompton & Harefield NHS Foundation Trust	N/A
Completed	eRT Remote Health Monitoring NCT01495780	University of California, Los Angeles	N/A
Completed	Do the SPPB and 4-metre Gait Speed Predict Hospital Readmission in Patients Hospitalised for Acute Exacerbatio NCT01507415	Royal Brompton & Harefield NHS Foundation Trust	—
Completed	Is the Short Physical Performance Battery a Useful Outcome Measure in Chronic Obstructive Pulmonary Disease NCT01515709	Royal Brompton & Harefield NHS Foundation Trust	—
Completed	Eccentric Exercise Training as Novel Rehabilitation for Chronic Obstructive Pulmonary Disease (COPD) NCT01077102	McGill University Health Centre/Research Institute of the McGill University Health Centre	N/A
Completed	Airway Macrophages and Sputum Milieu in Adult Subjects With Airflow Obstruction NCT00871637	University of Nebraska	—
Withdrawn	Safety and Efficacy of 4-weeks Treatment of BIBW 2948 BS in Patients With Chronic Obstructive Bronchitis NCT00726479	Boehringer Ingelheim	Phase 2
Completed	AVANTI - Avelox® in Acute Exacerbations of chroNic bronchiTIs NCT00846911	Bayer	—
Active Not Recruiting	Examining the Genetic Factors That May Cause Chronic Obstructive Pulmonary Disease (COPD) NCT00608764	Brigham and Women's Hospital	—
Completed	Effect of BIBW 2948 BS in COPD NCT00423137	Boehringer Ingelheim	Phase 2
Completed	Innate Immune Response in COPD NCT02637219	VA Puget Sound Health Care System	—
Terminated	Telithromycin in Acute Exacerbation of Chronic Bronchitis NCT00288223	Sanofi	Phase 4
Completed	Outcomes of Patients Not Responding to Antibiotics in the Community NCT00245427	CPL Associates	N/A
Withdrawn	Outpatient Registry Trial of Respiratory Tract Infections in Adults NCT00245453	CPL Associates	Phase 4
Completed	The Effect of Breathing Helium-Hyperoxia During Pulmonary Rehabilitation in Patients With COPD NCT00406705	University of Alberta	Phase 2
Completed	Intermittent Moxifloxacin Therapy For The Prevention Of Acute Exacerbations In Patients With Chronic Bronchiti NCT00473460	Bayer	Phase 3
Completed	Greatest International Antiinfective Trial With Avelox NCT00932802	Bayer	—
Completed	A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for NCT00644449	Pfizer	Phase 3
Completed	Telithromycin: in the Treatment of Acute Exacerbation of Chronic Bronchitis in Adult Outpatients With COPD NCT00538148	Sanofi	Phase 4
Completed	A Multicentre, Randomised, Open-Label Study To Compare The Efficacy And Safety Of Azithromycin For 5 Days With NCT00649831	Pfizer	Phase 3
Completed	A Blinded Study Comparing the Safety and Efficacy of a Fully Human Anti-IL8 Monoclonal Antibody (ABX-IL8) to P NCT00035828	Abgenix	Phase 2
Completed	COPD on Primary Care Treatment (COOPT) NCT00184977	Radboud University Medical Center	Phase 4
Completed	A Study of the Safety and Effectiveness of Oral Levofloxacin Compared With Cefuroxime Axetil in the Treatment NCT00269932	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 3
Completed	A Study of the Safety and Effectiveness of Levofloxacin Compared With Cefaclor in the Treatment of Adults With NCT00257140	Johnson & Johnson Pharmaceutical Research & Development, L.L.C.	Phase 2 / Phase 3